Literature DB >> 25110720

Infections and inflammation in prostate cancer.

Karen S Sfanos1, William B Isaacs2, Angelo M De Marzo3.   

Abstract

The frequent observation of both acute and chronic inflammation of unknown stimulus in the adult prostate has motivated a large body of research aimed at identifying potential infectious agents that may elicit prostatic inflammation. The overarching hypothesis is that infection-induced inflammation may be associated with prostate cancer development or progression, as inflammation is known to serve as an "enabling characteristic" of cancer. With recent advances in molecular techniques for microorganism identification, a panoply of microorganisms has been scrutinized in prostate tissues and in relation to prostate carcinogenesis. The aim of this review is to summarize the current literature on the evidence for infectious agents as a contributing factor to prostatic inflammation and prostate cancer, and to highlight recent literature suggesting an infectious etiology to the biogenesis of prostatic corpora amylacea and on the development of mouse models of prostatic infections.

Entities:  

Keywords:  Infections; acute inflammation; animal models; chronic inflammation; prostate cancer; prostatitis

Year:  2013        PMID: 25110720      PMCID: PMC4219279     

Source DB:  PubMed          Journal:  Am J Clin Exp Urol        ISSN: 2330-1910


  63 in total

1.  Amyloid in prostatic corpora amylacea.

Authors:  P A Cross; C J Bartley; J McClure
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

2.  Absence of bacterial imprints on struvite-containing kidney stones: a structural investigation at the mesoscopic and atomic scale.

Authors:  Dominique Bazin; Gilles André; Raphael Weil; Guy Matzen; Veron Emmanuel; Xavier Carpentier; M Daudon
Journal:  Urology       Date:  2011-11-23       Impact factor: 2.649

3.  Acne in adolescence and cause-specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort Study.

Authors:  B Galobardes; G Davey Smith; M Jeffreys; S Kinra; P McCarron
Journal:  Am J Epidemiol       Date:  2005-06-15       Impact factor: 4.897

4.  Prostatic calculi and neoplasm.

Authors:  M GOLDEN; B S ABESHOUSE
Journal:  Sinai Hosp J (Balt)       Date:  1952-03

Review 5.  Thirty years of research on infection and prostate cancer: no conclusive evidence for a link. A systematic review.

Authors:  Jan Hrbacek; Michael Urban; Eva Hamsikova; Ruth Tachezy; Jiri Heracek
Journal:  Urol Oncol       Date:  2012-03-28       Impact factor: 3.498

6.  P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.

Authors:  Anja Rogler; Michael Rogenhofer; Albert Borchardt; Jens-Claudio Lunz; Antje Knoell; Ferdinand Hofstaedter; Andrea Tannapfel; Wolf Wieland; Arndt Hartmann; Robert Stoehr
Journal:  Pathobiology       Date:  2011-07-19       Impact factor: 4.342

7.  Sexually transmissible infections and prostate cancer risk.

Authors:  Wen-Yi Huang; Richard Hayes; Ruth Pfeiffer; Raphael P Viscidi; Francis K Lee; Yun F Wang; Douglas Reding; Denise Whitby; John R Papp; Charles S Rabkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

8.  Coagulase-negative staphylococcus in chronic prostatitis.

Authors:  J C Nickel; J W Costerton
Journal:  J Urol       Date:  1992-02       Impact factor: 7.450

9.  Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial.

Authors:  Siobhan Sutcliffe; John F Alderete; Cathee Till; Phyllis J Goodman; Ann W Hsing; Jonathan M Zenilman; Angelo M De Marzo; Elizabeth A Platz
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

10.  Aggressiveness of inflammation in histological prostatitis--correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy.

Authors:  G Stimac; A Reljic; B Spajic; J Dimanovski; B Ruzic; M Ulamec; Z Sonicki; O Kraus
Journal:  Scott Med J       Date:  2009-08       Impact factor: 0.729

View more
  36 in total

Review 1.  The inflammatory microenvironment and microbiome in prostate cancer development.

Authors:  Karen S Sfanos; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Nat Rev Urol       Date:  2017-10-31       Impact factor: 14.432

Review 2.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

3.  Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple Sites.

Authors:  Karen S Sfanos; Kirstie Canene-Adams; Heidi Hempel; Shu-Han Yu; Brian W Simons; Anthony J Schaeffer; Edward M Schaeffer; William G Nelson; Angelo M De Marzo
Journal:  Cancer Prev Res (Phila)       Date:  2015-05-19

Review 4.  Metagenomics in diagnosis and improved targeted treatment of UTI.

Authors:  Matthew Dixon; Maria Stefil; Michael McDonald; Truls Erik Bjerklund-Johansen; Kurt Naber; Florian Wagenlehner; Vladimir Mouraviev
Journal:  World J Urol       Date:  2019-04-03       Impact factor: 4.226

5.  PET imaging of bacterial infections with fluorine-18-labeled maltohexaose.

Authors:  Xinghai Ning; Wonewoo Seo; Seungjun Lee; Kiyoko Takemiya; Mohammad Rafi; Xuli Feng; Daiana Weiss; Xiaojian Wang; Larry Williams; Vernon M Camp; Malveaux Eugene; W Robert Taylor; Mark Goodman; Niren Murthy
Journal:  Angew Chem Int Ed Engl       Date:  2014-10-21       Impact factor: 15.336

6.  Hematologic Markers and Prostate Cancer Risk: A Prospective Analysis in UK Biobank.

Authors:  Eleanor L Watts; Aurora Perez-Cornago; Jaimal Kothari; Naomi E Allen; Ruth C Travis; Timothy J Key
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-26       Impact factor: 4.254

7.  STAT3 is a key pathway in primary intraosseous squamous cell carcinoma arising from an odontogenic keratocyst.

Authors:  Ling Zhang; Shu-Li Liu; Wei-Min Ye; Jing Zheng
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

8.  Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer.

Authors:  Eva Shrestha; James R White; Shu-Han Yu; Ibrahim Kulac; Onur Ertunc; Angelo M De Marzo; Srinivasan Yegnasubramanian; Leslie A Mangold; Alan W Partin; Karen S Sfanos
Journal:  J Urol       Date:  2017-08-07       Impact factor: 7.450

9.  Association of interleukin-6 (-174 G/C) polymorphism with the prostate cancer risk: A meta-analysis.

Authors:  Mingyuan Yang; Chao Li; Ming Li
Journal:  Biomed Rep       Date:  2014-06-16

Review 10.  Inflammatory mediators in the development and progression of benign prostatic hyperplasia.

Authors:  Cosimo De Nunzio; Fabrizio Presicce; Andrea Tubaro
Journal:  Nat Rev Urol       Date:  2016-09-30       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.